Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-07-01 Sale | 2025-07-02 4:25 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 9,208 | $13.84 | $127,430 | 100,206 (Direct) | View |
| 2025-06-18 Sale | 2025-06-20 4:32 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 10,139 | $13.37 | $135,574 | 109,414 (Direct) | View |
| 2025-06-13 Purchase | 2025-06-17 5:45 pm | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director | 2,646 | $13.08 | $34,610 | 8,862,862 (Indirect Direct) | View |
| 2025-06-04 Purchase | 2025-06-06 08:44 am | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director | 2,268 | $13.34 | $30,247 | 8,852,607 (Indirect Direct) | View |
| 2025-05-28 Sale | 2025-05-29 8:25 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks | 1,800 | $13.78 | $24,807 | 202,599 (Direct) | View |
| 2025-05-21 Purchase | 2025-05-23 4:04 pm | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director | 5,040 | $13.65 | $68,821 | 8,850,339 (Indirect Direct) | View |
| 2025-05-19 Sale | 2025-05-20 4:37 pm | Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd See Remarks | 7,451 | $14.07 | $104,850 | 183,104 (Direct) | View |
| 2025-05-15 Purchase | 2025-05-19 4:14 pm | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director | 2,520 | $13.62 | $34,317 | 8,845,299 (Indirect Direct) | View |
| 2025-05-13 Purchase | 2025-05-15 4:18 pm | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director | 8,674 | $13.76 | $119,352 | 8,842,779 (Indirect Direct) | View |
| 2025-05-09 Purchase | 2025-05-13 4:11 pm | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director | 6,300 | $13.6 | $85,691 | 8,834,105 (Indirect Direct) | View |
| 2025-05-08 Sale | 2025-05-09 7:45 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 3,871 | $13.59 | $52,623 | 115,468 (Direct) | View |
| 2025-05-02 Sale | 2025-05-05 5:20 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks | 5,030 | $15.2 | $76,453 | 204,399 (Direct) | View |
| 2025-05-02 Sale | 2025-05-05 5:20 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 11,448 | $15.19 | $173,917 | 1,144,935 (Indirect Direct) | View |
| 2025-05-02 Sale | 2025-05-05 5:20 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 2,597 | $15.19 | $39,442 | 119,339 (Direct) | View |
| 2025-05-01 Sale | 2025-05-05 4:49 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 10,000 | $14.64 | $146,357 | 111,944 (Direct) | View |
| 2025-04-01 Sale | 2025-04-03 4:21 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 10,000 | $15.12 | $151,236 | 121,944 (Direct) | View |
| 2025-04-02 Sale | 2025-04-03 4:21 pm | Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer | 9,600 | $15.8 | $151,698 | 182,774 (Direct) | View |
| 2025-03-24 Sale | 2025-03-26 4:41 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 3,671 | $17.55 | $64,413 | 1,156,383 (Indirect Direct) | View |
| 2025-03-17 Sale | 2025-03-20 6:27 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 1,200 | $17.61 | $21,137 | 1,160,054 (Indirect Direct) | View |
| 2025-03-13 Sale | 2025-03-17 4:51 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 61,403 | $14.99 | $920,510 | 536,678 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 7:44 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 3,773 | $13.1 | $49,408 | 308,089 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 7:43 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 25,015 | $13.07 | $327,019 | 1,557,254 (Indirect Direct) | View |
| 2025-03-03 Sale | 2025-03-04 7:43 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 10,000 | $13 | $130,048 | 131,944 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 7:43 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks | 3,263 | $13.03 | $42,520 | 298,429 (Direct) | View |
| 2025-02-03 Sale | 2025-02-04 8:01 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks | 8,338 | $12.7 | $105,893 | 178,692 (Direct) | View |
| 2025-02-03 Sale | 2025-02-04 8:01 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 19,301 | $12.7 | $245,123 | 1,035,269 (Indirect Direct) | View |
| 2025-02-03 Sale | 2025-02-04 8:00 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 10,000 | $12.71 | $127,100 | 141,944 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-12 Option Award | 2025-06-16 8:18 pm | N/A 2035-06-12 | Arcutis Biotherapeutics Inc. | ARQT | LIN SUE-JEAN Director | 28,177 | $0 | 47,303 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 8:17 pm | N/A 2035-06-12 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 28,177 | $0 | 140,121 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 8:17 pm | N/A 2035-06-12 | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner | 28,177 | $0 | 8,880,784 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 8:17 pm | N/A 2035-06-12 | Arcutis Biotherapeutics Inc. | ARQT | Leonard Keith R Director | 28,177 | $0 | 48,753 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 8:17 pm | N/A 2035-06-12 | Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director | 28,177 | $0 | 38,316 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 8:17 pm | N/A 2035-06-12 | Arcutis Biotherapeutics Inc. | ARQT | Krishnamohan Neha Director | 28,177 | $0 | 43,923 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 8:17 pm | N/A 2035-06-12 | Arcutis Biotherapeutics Inc. | ARQT | Gilbert Halley E Director | 28,177 | $0 | 47,003 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 8:16 pm | N/A 2035-06-12 | Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director | 28,177 | $0 | 938,375 (Direct) | View |
| 2025-06-10 Gift | 2025-06-12 4:53 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 997 | $0 | 1,120,840 (Direct) | View |
| 2025-05-06 Option Award | 2025-05-07 7:29 pm | N/A 2035-05-06 | Arcutis Biotherapeutics Inc. | ARQT | Vairavan Latha SVP Chief Financial Officer | 80,000 | $0 | 125,104 (Direct) | View |
Ownership | 2025-05-07 7:27 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Vairavan Latha SVP Chief Financial Officer | 0 | $0 | 122,854 (Direct) | View |
| 2025-03-13 Exercise | 2025-03-17 4:51 pm | N/A 2034-01-12 | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 17,250 | $0 | 536,678 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 7:44 pm | N/A 2035-02-28 | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 197,000 | $0 | 308,089 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 7:43 pm | N/A 2035-02-28 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks | 547,000 | $0 | 1,557,254 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 7:43 pm | N/A 2035-02-28 | Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer | 123,000 | $0 | 281,374 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 7:43 pm | N/A 2035-02-28 | Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd See Remarks | 197,000 | $0 | 332,555 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 7:43 pm | N/A 2035-02-28 | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks | 123,000 | $0 | 298,429 (Direct) | View |